FDA Warning Letter — Aurobindo Pharma Limited
The FDA took a Warning Letter action against Aurobindo Pharma Limited on May 20, 2011 (Sangareddy, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Aurobindo Pharma Limited
- Date
- May 20, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Center
- CDER
- Location
- Sangareddy (India)